Wednesday, December 8, 2021

SPARC inks licensing pact with Visiox Pharma for ophthalmic products

SPARC inks licensing pact with Visiox Pharma for ophthalmic products The company has entered into an agreement with Visiox Pharma LLC (Visiox) to grant exclusive worldwide rights (except for India and Greater China) for the development and commercialisation of PDP-716 and SDN-037, SPARC said in a statement.

from Moneycontrol Business News https://ift.tt/3IumBz4
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Rupee ends weak at 90.19 against the dollar, bond yields rise

The Indian rupee weakened slightly on Tuesday, closing at 90.19 against the dollar. This dip followed news that Indian bonds will not be inc...